MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-01-0085003
Nirvitta Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹28.41 Cr
▲ 11% YoY
Net profit · FY 2025
₹46.34 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹84.52 Lakh
EBITDA margin 3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Nirvitta Pharmaceuticals Private Limited
Data last updated:
Nirvitta Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2020PTC117388. Its GSTIN is 24AAHCN2271J1ZG (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Shipra and Prateek.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 219 Second Floor Celebration City Centre South Bopal, Ahmedabad, Gujarat, India – 380058.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.41 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹46.34 Lakh (net margin 1.6%) and EBITDA of ₹84.52 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 76% over three years.
Nirvitta Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0085003). For more details, the company can be reached via its website nirvittapharmaceuticals.com.
Company Details of Nirvitta Pharmaceuticals Private Limited
CIN U51909GJ2020PTC117388
Registration Number 117388
Incorporation Date 16 October 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-GJ-01-0085003
Key People
Shipra Director Prateek Director Recognitions & Rankings of Nirvitta Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA – 219 Second Floor Celebration City Centre South Bopal, Ahmedabad, Gujarat, India – 380058
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Nirvitta Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Nirvitta Pharmaceuticals Private Limited
The main business activity of Nirvitta Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nirvitta Pharmaceuticals Private Limited FY 2025 filings available
Nirvitta Pharmaceuticals Private Limited reported revenue of ₹28.41 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹28.41 Cr ▲ 11%
Net profit · FY 2025
₹46.34 Lakh margin 1.6%
EBITDA · FY 2025
₹84.52 Lakh margin 3%
Compounded Annual Growth Rate (CAGR) of Nirvitta Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 76%
EBITDA CAGR growth
3 years · compounded
▲ 70%
Revenue has grown at a compounded annual rate (CAGR) of 76% over three years, including 11% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nirvitta Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹84.52 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹46.34 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nirvitta Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nirvitta Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shipra Also directs: Nirvitta Lifestyle Private Limited | Director | 16 Oct 2020 | 6 Years 0 Months | Current |
| Prateek Also directs: Nirvitta Lifestyle Private Limited | Director | 16 Oct 2020 | 6 Years 0 Months | Current |
Peer Comparison of Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curehealth Pharmaceuticals Private Limited | ₹29.03 Cr (FY 2024) | •••• | •••• | 47.0% | •••• | Chandigarh, India |
| Monique Pharmaceuticals Private Limited | ₹28.97 Cr (FY 2024) | •••• | •••• | -51.0% | •••• | New Delhi, Delhi, India |
| Stantech Pharmaceuticals Private Limited | ₹28.91 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Dycine Pharmaceuticals Limited | ₹28.83 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Noida, Uttar Pradesh, India |
| Perdaman Pharmaceuticals Private Limited | ₹28.76 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Nirvitta Pharmaceuticals Private Limited this company | ₹28.41 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Ahmedabad, Gujarat, India |
| Xellia Pharmaceuticals Private Limited | ₹28.32 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Bangalore, Karnataka, India |
| Inven Pharmaceuticals Private Limited | ₹27.99 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Indore, Madhya Pradesh, India |
| Shreepati Pharmaceuticals Pvt Ltd | ₹27.91 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Indore, M.P, Madhya Pradesh, India |
| Sellwell Pharmaceuticals Limited | ₹27.85 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Madhya Pradesh, India |
| Synac Pharmaceuticals Private Limited | ₹27.79 Cr (FY 2025) | •••• | •••• | 311.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Nirvitta Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals Private Limited is audited by MOHIT GOEL & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MOHIT GOEL & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nirvitta Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Prateek was appointed as Director on 16 Oct 2020.
AGM
Nirvitta Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nirvitta Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Prateek was appointed as Director.
Appointed
Shipra was appointed as Director.
Incorporation
16 Oct 2020
Nirvitta Pharmaceuticals Private Limited was registered on 16 Oct 2020 with Roc Ahmedabad & aged 6 years 5 days as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Nirvitta Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nirvitta Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nirvitta Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCN2271J1ZG | Gujarat | Active | 25 Jan 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nirvitta Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirvitta Pharmaceuticals Private Limited
Nirvitta Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 October 2020 (6+ years old) and is registered under CIN U51909GJ2020PTC117388.
Nirvitta Pharmaceuticals reported revenue of ₹28.41 Cr for FY 2025 (up 11% YoY).
Nirvitta Pharmaceuticals reported a net profit of ₹46.34 Lakh (net margin 1.6%) and EBITDA of ₹84.52 Lakh (EBITDA margin 3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nirvitta Pharmaceuticals is 76% over three years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nirvitta Pharmaceuticals is 24AAHCN2271J1ZG, registered in Gujarat.
The CIN (Corporate Identification Number) of Nirvitta Pharmaceuticals is U51909GJ2020PTC117388. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nirvitta Pharmaceuticals was incorporated on 16 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Nirvitta Pharmaceuticals by revenue are Curehealth Pharmaceuticals Private Limited, Monique Pharmaceuticals Private Limited, Stantech Pharmaceuticals Private Limited, Dycine Pharmaceuticals Limited, Perdaman Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Prateek was appointed as Director on 16 Oct 2020. Shipra was appointed as Director on 16 Oct 2020.
Yes, Nirvitta Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-GJ-01-0085003).